Dupilumab Subcutaneous and Glipizide Extended-Release Tablets
Determining the interaction of Dupilumab Subcutaneous and Glipizide Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: glipizide
Brand name: Glucotrol, Glucotrol XL, Glipizide XL
Synonyms: Glipizide, GlipiZIDE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Glipizide Tablets
- Dupilumab Subcutaneous-Glipizide XL
- Dupilumab Subcutaneous-Glofil-125
- Dupilumab Subcutaneous-Gloperba
- Dupilumab Subcutaneous-GloStrips
- Dupilumab Subcutaneous-Glucagen
- Glipizide Extended-Release Tablets-Dupixent
- Glipizide Extended-Release Tablets-Duplex T Topical
- Glipizide Extended-Release Tablets-Durachol
- Glipizide Extended-Release Tablets-Duraclon
- Glipizide Extended-Release Tablets-Duraclon injection
- Glipizide Extended-Release Tablets-Duraflu